Sitagliptin in the treatment of type 2 diabetes: a meta‐analysis | Semantic Scholar
@article{Zhan2012SitagliptinIT, title={Sitagliptin in the treatment of type 2 diabetes: a meta‐analysis}, author={Mei Zhan and Ting Xu and Fengbo Wu and Yao Tang}, journal={Journal of Evidence‐Based Medicine}, year={2012}, volume={5}, url={https://api.semanticscholar.org/CorpusID:205981406} }
The objective was to evaluate the benefits and harms of sitagliptin in people with type 2 diabetes mellitus and to establish a baseline level of trust in the use of the drug.
18 Citations
Assessment of β-Cell Function
- A. KrentzL. HeinemannM. Hompesch
- 2015
Medicine
These range from basal pharmacokinetic measures, e.g. measurement of fasting serum insulin concentration, to dynamic tests that measure insulin responses to glucose ± non-glucose stimuli, which have value in the early-phase development of new drugs for diabetes treatment.